US · Healthcare · Medical Devices
EPS came in at 0.03 against a street estimate of -0.01 — a beat of 400.0%.
Analysts rate Adapthealth Corp a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $9.14.
| Fund | Stake |
|---|---|
| OEP CAPITAL ADVISORS, L.P. | 12.23% |
| BlackRock Inc | 11.95% |
| Deerfield Management Co | 8.60% |
| SkyKnight Capital, L.P. | 6.43% |
| FMR Inc | 6.04% |
| Dimensional Fund Advisors, Inc. | 5.75% |
| Reinhart Mahoney Capital Management Inc | 5.56% |
| Vanguard Portfolio Management, LLC | 4.58% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 ADAPTHEALTH CORP. - FORM 8-K SUMMARY HEADLINE NUMBERS • New CFO base salary: $670,000 annually • New CFO target bonus: 100% of base salary ($670,000 | 2026-09-08 |
| Quarterly report · Q2 2026 ADAPTHEALTH CORP. – FORM 10-Q SUMMARY For Quarter Ended June 30, 2026 --- HEADLINE NUMBERS • Net Revenue (Q2 2026): $740.3 million | YoY: +12.7% vs | 2026-08-04 |
| Results announced · Q3 2026 ADAPTHEALTH CORP. – Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $740.3 million vs. $657.1 million Q2 2025 (+12.7%) • Organic re | 2026-08-04 |
| Material agreement · Q3 2026 ADAPTHELTH CORP. – FORM 8-K SUMMARY HEADLINE NUMBERS • Asset sale price: $235.0 million in cash for substantially all diabetes medical devices and s | 2026-07-20 |
| Reg FD disclosure · Q3 2026 ADAPTHEALTH CORP. – FORM 8-K SUMMARY HEADLINE NUMBERS • Debt Redemption Amount: $325,000,000 in 6.125% Senior Notes due 2028 being redeemed at 100% | 2026-07-07 |
| Quarterly report · Q1 2026 ADAPTHEALTH CORP. (AHCO) – Q1 2026 SUMMARY HEADLINE NUMBERS • Revenue Q1 2026: $819.8 million (up from $777.9 million in Q1 2025; +5.4% YoY) • Net L | 2026-05-05 |
| Proxy statement · Q2 2026 ADAPTHEALTH CORP. PROXY SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect nine directors for one-year terms: Gregory Belinfanti, Terence C | 2026-04-28 |
| Annual report FY2025 ADAPTHEALTH CORP. - 2025 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Market capitalization (as of June 30, 2025): approximately $1.04 billion • Outstan | 2026-02-24 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Adapthealth Corp — free to start.
Google PlayApp StoreData updated 2026-09-18.